Free Trial

Nyxoah (NYXH) Competitors

Nyxoah logo
$10.83 -0.08 (-0.73%)
As of 04:00 PM Eastern

NYXH vs. FNA, EYE, AXGN, CBLL, BVS, AVNS, IRMD, BFLY, SIBN, and KIDS

Should you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Paragon 28 (FNA), National Vision (EYE), AxoGen (AXGN), CeriBell (CBLL), Bioventus (BVS), Avanos Medical (AVNS), Iradimed (IRMD), Butterfly Network (BFLY), SI-BONE (SIBN), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

Nyxoah vs.

Paragon 28 (NYSE:FNA) and Nyxoah (NASDAQ:NYXH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

63.6% of Paragon 28 shares are owned by institutional investors. 15.3% of Paragon 28 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Paragon 28 has a net margin of -25.31% compared to Nyxoah's net margin of -1,043.93%. Paragon 28's return on equity of -37.90% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
Paragon 28-25.31% -37.90% -18.22%
Nyxoah -1,043.93%-51.68%-40.11%

In the previous week, Paragon 28 had 6 more articles in the media than Nyxoah. MarketBeat recorded 8 mentions for Paragon 28 and 2 mentions for Nyxoah. Paragon 28's average media sentiment score of 0.94 beat Nyxoah's score of 0.00 indicating that Paragon 28 is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Paragon 28
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nyxoah
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Nyxoah received 3 more outperform votes than Paragon 28 when rated by MarketBeat users. However, 83.33% of users gave Paragon 28 an outperform vote while only 71.70% of users gave Nyxoah an outperform vote.

CompanyUnderperformOutperform
Paragon 28Outperform Votes
35
83.33%
Underperform Votes
7
16.67%
NyxoahOutperform Votes
38
71.70%
Underperform Votes
15
28.30%

Paragon 28 has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500.

Paragon 28 currently has a consensus target price of $15.60, indicating a potential upside of 39.06%. Nyxoah has a consensus target price of $17.00, indicating a potential upside of 56.52%. Given Nyxoah's higher probable upside, analysts clearly believe Nyxoah is more favorable than Paragon 28.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Paragon 28
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Nyxoah has lower revenue, but higher earnings than Paragon 28. Paragon 28 is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Paragon 28$216.39M4.34-$57.53M-$0.74-15.16
Nyxoah$4.70MN/A-$46.77M-$1.87-5.81

Summary

Paragon 28 beats Nyxoah on 13 of the 18 factors compared between the two stocks.

Get Nyxoah News Delivered to You Automatically

Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NYXH vs. The Competition

MetricNyxoahSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market CapN/A$4.83B$5.39B$9.14B
Dividend YieldN/A52.58%5.37%4.00%
P/E Ratio-5.8026.0988.2717.52
Price / SalesN/A61.251,286.0780.21
Price / CashN/A50.8936.6032.90
Price / BookN/A7.904.954.68
Net Income-$46.77M$13.87M$117.96M$224.57M
7 Day Performance16.53%4.37%2.54%3.26%
1 Month Performance35.59%11.45%3.49%5.30%
1 Year Performance141.09%33.41%27.05%22.74%

Nyxoah Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NYXH
Nyxoah
2.7951 of 5 stars
$10.83
-0.7%
$17.00
+57.0%
+142.2%$0.00$4.70M-5.79110News Coverage
Positive News
FNA
Paragon 28
3.2297 of 5 stars
$10.70
+3.4%
$15.60
+45.8%
-3.8%$895.80M$245.00M-14.46343,000Gap Up
EYE
National Vision
2.7049 of 5 stars
$10.58
+0.6%
$13.50
+27.6%
-44.2%$833.18M$2.18B-52.9014,000Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
AXGN
AxoGen
1.5151 of 5 stars
$18.25
+1.1%
$15.00
-17.8%
+106.0%$803.15M$180.86M-57.03450Positive News
CBLL
CeriBell
N/A$20.84
-0.4%
$32.60
+56.4%
N/A$746.57M$60.04M0.00N/A
BVS
Bioventus
3.3721 of 5 stars
$9.16
-1.3%
$15.00
+63.8%
+109.2%$743.38M$555.06M-15.021,200
AVNS
Avanos Medical
4.072 of 5 stars
$15.84
+4.2%
N/A-15.6%$727.96M$681.50M46.593,771Short Interest ↓
IRMD
Iradimed
4.6047 of 5 stars
$56.51
-0.1%
$60.00
+6.2%
+33.4%$716.15M$71.31M38.71110
BFLY
Butterfly Network
1.0295 of 5 stars
$3.35
-6.7%
$3.00
-10.4%
+246.3%$713.76M$76.22M-7.28460Gap Up
SIBN
SI-BONE
4.2672 of 5 stars
$16.23
+18.3%
$23.00
+41.7%
-10.0%$680.65M$157.04M-17.64350High Trading Volume
KIDS
OrthoPediatrics
4.1575 of 5 stars
$25.00
+2.3%
$39.00
+56.0%
-5.8%$605.40M$189.67M-20.33200Short Interest ↑

Related Companies and Tools


This page (NASDAQ:NYXH) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners